GE HealthCare And Mayo Clinic Launch GEMINI-RT, Strategic Initiative To Personalize Radiation Therapy By Integrating Imaging, AI, And Patient Monitoring Across Cancer Care Continuum

• GE HealthCare and Mayo Clinic launch GEMINI-RT, a strategic initiative to personalize radiation therapy by integrating imaging, AI, and patient monitoring across the cancer care continuum.
• The collaboration focuses on four pillars, automation, predictive oncology, multi-modal therapies, and outpatient monitoring, with the aim to enhance clinical outcomes, reduce clinician burnout, and accelerate innovation in radiation oncology.

GE HealthCare (NASDAQ:GEHC) and Mayo Clinic today announced the GE HealthCare-Mayo Clinic Initiative in Radiation Therapy, known as GEMINI-RT, an ambitious new collaboration that aims to transform personalized radiation therapy and cancer care. Building on decades of collaboration and the original Strategic Radiology Research Collaboration signed in 2023, GEMINI-RT plans to drive innovation in prediction, planning, automation, workflow and monitoring for radiation oncology.

GEMINI-RT combines Mayo Clinic's world-class clinical and research expertise with GE HealthCare's leading technical and engineering innovation in oncology care and radiation therapy. The initiative aims to deliver comprehensive, personalized care by exploring integrating imaging, advanced therapies, dosimetry, and patient monitoring at every step of the patient journey—from detection and diagnosis to treatment and follow-up.